Aprea Therapeutics (APRE) Operating Leases (2019 - 2022)
Aprea Therapeutics (APRE) posted quarterly Operating Leases of $28061.0 for Q1 2022, down 16.89% year-over-year from $33763.0 in Q1 2021, and down 5.75% quarter-over-quarter from $29773.0 in Q3 2021.
Aprea Therapeutics (APRE) Operating Leases (2019 - 2022) Analysis & Trends
Aprea Therapeutics (APRE) has reported Operating Leases for 4 consecutive years, with $28061.0 the latest figure, recorded in Q1 2022.
- In Q1 2022, Operating Leases fell 16.89% year-over-year to $28061.0; the TTM figure through Mar 2022 stood at $28061.0 (down 16.89% YoY), while the FY2020 annual figure was $78847.0, down 73.95% from the prior year.
- Operating Leases eased to $28061.0 in Q1 2022 per APRE's latest filing, from $29773.0 in the prior quarter.
- Across five years, Operating Leases topped out at $358404.0 in Q3 2019 and bottomed at $28061.0 in Q1 2022.
- Historically, Operating Leases has averaged $153050.7 across 4 years, with a median of $132773.0 in 2020.
- Annual changes were most pronounced in 2021 — Operating Leases plunged 85.15% — and 2022, when it decreased 16.89%.
- Aprea Therapeutics' Operating Leases stood at $302621.0 in 2019, then slumped by 73.95% to $78847.0 in 2020, then sank by 62.24% to $29773.0 in 2021, then slipped by 5.75% to $28061.0 in 2022.
- Business Quant data shows APRE's Operating Leases at $28061.0 in Q1 2022, $29773.0 in Q3 2021, and $33763.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Aprea Therapeutics | 34.28 Mn | 34.28 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 28,061.00 |
| Sep 30, 2021 | 29,773.00 |
| Mar 31, 2021 | 33,763.00 |
| Dec 31, 2020 | 78,847.00 |
| Sep 30, 2020 | 132,773.00 |
| Jun 30, 2020 | 185,926.00 |
| Mar 31, 2020 | 227,288.00 |
| Dec 31, 2019 | 302,621.00 |
| Sep 30, 2019 | 358,404.00 |